Nothing Special   »   [go: up one dir, main page]

Costa et al., 2021 - Google Patents

Secukinumab on refractory lupus nephritis

Costa et al., 2021

View HTML
Document ID
12622345686657584414
Author
Costa R
Antunes P
Salvador P
Oliveira P
Marinho A
Publication year
Publication venue
Cureus

External Links

Snippet

Lupus nephritis (LN) is the most frequent severe organ manifestation of systemic lupus erythematosus (SLE). About 30% of patients are refractory to treatment. The authors report a case of treatment of LN with interleukin-17-targeted therapy, demonstrating its possible …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Watts et al. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology
Ge et al. The structure, specificity and function of anti-citrullinated protein antibodies
Costa et al. Secukinumab on refractory lupus nephritis
Byrd et al. Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa
Borgia et al. Features, treatment, and outcomes of macrophage activation syndrome in childhood‐onset systemic lupus erythematosus
Beltrán et al. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
Parodis et al. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus
Grotz et al. Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge
Peco-Antic et al. Childhood microscopic polyangiitis associated with MPO-ANCA
Gmuca et al. Juvenile spondyloarthritis
Zhou et al. Aberrant T cell subsets and cytokines expression profile in systemic lupus erythematosus
Schiaffino et al. Immunoserologic detection and diagnostic relevance of cross-reactive autoantibodies in coronavirus disease 2019 patients
Lu et al. Differences in clinical characteristics of IgG4-related disease across age groups: a prospective study of 737 patients
Premužić et al. The Association of TNF‐Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes
Avouac et al. Semaphorins: From angiogenesis to inflammation in rheumatoid arthritis
Provencher et al. Urinary β2-microglobulin and disease activity in patients with tubulointerstitial nephritis and uveitis syndrome
Aguilar et al. Tubulointerstitial nephritis and uveitis syndrome: case report and review of the literature
Shi et al. Thrombocytopenia in primary antiphospholipid syndrome: association with prognosis and clinical implications
Singh et al. Analysis of CXCR5+ Th17 cells in relation to disease activity and TNF inhibitor therapy in Rheumatoid Arthritis
Appelgren et al. Active NET formation in Libman–Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus
Younger Overview of the vasculitides
Pritzker Blood-based biomarkers of chronic inflammation
Sinangil et al. Synthetic cannabinoid induced acute tubulointerstitial nephritis and uveitis syndrome: A case report and review of literature
Pak et al. Delay in the diagnosis of adult-onset Still’s disease
Bassyouni et al. Autoantibodies against complement C1q in patients with Behcet’s disease: Association with vascular involvement